en · de · es · fr · pt
bench-notes.peptides6088.com › News › Mechanism And Regulatory Status — Field Notes

Mechanism And Regulatory Status — Field Notes

By Editorial Desk · published 2025-10-22 · last reviewed 2025-11-29 · News

This is a working overview of peptide research, written for readers who want more than a one-paragraph summary but less than a textbook.

Reviewed 2025-11-29. Anything still debated is marked as such rather than presented as settled.

Mechanism and Regulatory Status

Clinical development of AOD-9604 included trials in people with obesity. Reports from early-phase and mid-phase studies described modest or inconsistent changes in body weight. A phase IIb program did not meet its primary endpoint, and the compound was not approved for medical use. Differences in formulation, delivery route, and participant characteristics may explain some of the variation. Later investigations explored whether the peptide might have effects in other tissues, including cartilage.

Regulatory treatment of AOD-9604 is shaped by its classification as a peptide hormone. The World Anti-Doping Agency lists it as a prohibited substance, and many national anti-doping organizations adopt that list. It does not hold approval as a prescription medicine in the United States, the European Union, or other major markets. Products sold online are frequently labeled for research use only and may not undergo independent quality testing. Import and possession rules differ by country, so legal status depends on local law.

Background And Research Context

In the scientific literature, AOD-9604 appears in reviews of growth hormone fragments and in discussions of peptide-based metabolic research. Some sources distinguish it from growth hormone itself, while others group it with compounds marketed for weight management. The evidence base is small compared with approved obesity medications. Questions about long-term efficacy and clinical relevance remain open, and independent replication of key findings is limited. Most published reports are early-stage and exploratory.

AOD-9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It is often described as hGH fragment 176-191. Research interest arose because it was designed to isolate possible effects on fat metabolism from other actions of growth hormone. It is not a full growth hormone molecule. Its development history includes early laboratory and animal studies followed by human trials. The peptide has been examined in laboratory, animal, and limited human studies.

Aod-9604 at a glance

PropertyValueNotes
Typical storage temperature-20 °CLyophilized peptide; protect from moisture and light.
Typical analytical methodHPLC and mass spectrometryUsed to confirm identity and estimate purity.
Common synonymsAOD9604; hGH 176-191Naming varies by supplier and publication.
Disulfide bondsOneAffects folded structure and stability.
Typical research purity≥95%Value depends on supplier and analytical method.

Measurement and Storage Practices

Stability of AOD-9604 depends on storage conditions. Lyophilized powder is generally more stable than reconstituted solution. Recommended storage is typically at -20°C or lower, protected from light and moisture. Repeated freeze-thaw cycles can cause aggregation or degradation. In solution, the peptide may be susceptible to hydrolysis or oxidation, so aliquoting and cold storage are common practices. Researchers often add stabilizers such as mannitol or trehalose during lyophilization to improve shelf life.

Quality control for AOD-9604 involves verifying identity, purity, and concentration. Suppliers may provide a certificate of analysis listing HPLC purity and mass spectrometry data. Independent verification is advised because peptide products can vary in quality. Researchers should check for counterions, residual solvents, and microbial contamination. Proper documentation supports reproducibility and safety in laboratory studies. When sourcing, institutions often require third-party testing and detailed chain-of-custody records. These steps help ensure that experimental results are attributable to the peptide rather than impurities.

Related pages on this site

Identity and Research Context

Early interest in AOD-9604 centered on whether a fragment of human growth hormone could influence fat metabolism without the broader effects of the full hormone. Cell and animal studies reported changes in fat storage and breakdown. Human trials followed, but the results were not strong enough to secure regulatory approval. The compound remains available for laboratory research, and its clinical potential is still described as uncertain. Studies continue to examine its activity and safety profile.

AOD-9604 is a synthetic peptide that corresponds to a short section of human growth hormone. It is commonly identified as hGH fragment 176-191 because its sequence matches residues at the C-terminal end of the hormone. The molecule contains sixteen amino acids and is made by solid-phase peptide synthesis. Researchers study it for metabolic effects rather than for the growth-promoting actions associated with full human growth hormone. Its small size distinguishes it from the complete 191-amino-acid hormone.

Research and Regulatory Status

Research interest in AOD-9604 often focuses on whether it can influence lipid metabolism without the growth-promoting or glucose-related effects of full-length hGH. This question remains unresolved, and findings depend on model, dose, and measurement method. Some reviews treat the peptide as a historical obesity candidate rather than an active therapeutic. Others cite it in discussions of peptide fragments, metabolic signaling, and performance-enhancing substances. Clear conclusions are limited by the small number of rigorous, independent human studies.

AOD-9604 has been investigated primarily as a potential treatment for obesity and related metabolic conditions. Early laboratory work examined its effects on fat cells, and later studies moved into animal models and human clinical trials. Some trials reportedly reached Phase II, but the program did not lead to an approved medicine. Published summaries often note that weight-loss results were modest or inconsistent. The full trial data are not all publicly available in detail.

Notes from published material

isoelectronicity The phenomenon of two or more chemical species (atoms, molecules, ions, etc.) being composed of different elements but having the same number of valence electrons and the same structural arrangement (i.e. the same number of atoms with the same connectivity). Isoelectronic species typically show useful consistency and predictability in their chemical properties.

=== June === 1 June – A bioRxiv preprint reports the first use of base editing to alter the genome of early human embryos. Researchers at Columbia University used the technique to introduce precise single-letter DNA changes without the large chromosomal alterations previously associated with double-strand-break CRISPR gene editing, while noting that the approach remains far from clinical use and raises ethical questions over human germline engineering. 3 June – A report by the United Nations University Institute for Water, Environment and Health estimates that global data centre electricity consumption could reach 945 TWh by 2030, driven partly by growing demand for artificial intelligence, with associated water use rising to 9.3 trillion litres and carbon dioxide emissions to 399 million tonnes. 4 June – Chinese researchers discover the two-state model of liquid water theorizing that water is composed of two distinct and interconvertible local structures at the high and low density phase boundary. 5 June – Researchers at the University of Cambridge and DIOSynVax report the first human clinical trial of a vaccine whose active component was designed entirely by computer simulations. The candidate pan-Sarbecovirus vaccine, pEVAC-PS, uses a machine-learning-designed "super-antigen"; a phase I trial in 39 healthy volunteers finds it safe and able to trigger immune responses to SARS-CoV-2, SARS-CoV-1, and related bat coronaviruses.

Labcorp was an early pioneer of genomic testing using polymerase chain reaction (PCR) technology at its Center for Molecular Biology and Pathology in Research Triangle Park, North Carolina, where it also performs other molecular diagnostics. Labcorp operates the National Genetics Institute, Inc. (NGI), in Los Angeles, California, which develops PCR testing methods.

== Research and career == In the 1980s, Mojsov moved to the Massachusetts General Hospital (MGH) where she was made head of a peptide synthesis facility. She arrived at MGH shortly after Joel Habener had cloned proglucagon by studying anglerfish found in Boston Harbor. Mojsov worked on the identification of glucagon-like peptide-1 (GLP-1), a hormone generated by the gut that triggers the release of insulin. The amino acid sequence of GLP-1 was similar to a gastric inhibitory peptide, an incretin. To try to identify whether a specific fragment of GLP-1 was an incretin, Mojsov synthesized an incretin-antibody and developed ways to track its presence. Specifically, Mojsov identified that a stretch of 31 amino acids in the GLP-1 was an incretin. Together with Gordon Weir at the Joslin Diabetes Center in Boston and Habener, Mojsov showed that physiologic concentration of 5 × 10−11 of lab-synthesized GLP-1 could trigger insulin. All other reports at that time were for much higher concentrations thus not meeting Cretuzfeld's requirement that an incretin "must stimulate insulin secretion in a glucose-dependent manner at physiological levels". In the 1990s, Mojsov returned to New York City, where she went back to Rockefeller University and the laboratory of Ralph M. Steinman (2011 Nobel Prize in Physiology or Medicine). In 1992, the group at Massachusetts General Hospital (MGH) using GLP-1 synthesized by Mojsov tested the GLP-1 in humans. Drugs that emulate the action of GLP-1 have been developed into treatments for obesity and diabetes by Novo Nordisk and Eli Lilly.

== Effects of consumption == The nature of effects will largely depend on the cultivar of the kava plant and the form of its consumption. Traditionally, only noble kava cultivars have been consumed, as they are accepted as safe and produce desired effects. The specific effects of various noble kavas depend on various factors, such as the cultivar used (and the related specific composition of kavalactones), age of the plant, and method of consumption. However, it can be stated that in general, noble kava produces a state of calmness, relaxation, and well-being without diminishing cognitive performance. Kava may produce an initial talkative period, followed by muscle relaxation and eventual sleepiness. The beverage has initial numbing and astringent effect in the mouth caused by the local anesthetic action of kavalactones and chewing it has local anesthetic effects similar to that of cocaine and longer lasting than benzocaine. As noted in one of the earliest Western publications on kava (1886): "A well prepared Kava potion drunk in small quantities produces only pleasant changes in behavior. It is therefore a slightly stimulating drink which helps relieve great fatigue. It relaxes the body after strenuous efforts, clarifies the mind and sharpens the mental faculties". Despite its psychoactive effects, kava is not considered to be physically addictive and its use does not lead to dependency.

Sources: en.wikipedia.org

Further detail

Detlev Peukert (September 20, 1950 in Gütersloh – May 17, 1990 in Hamburg) was a German historian, noted for his studies of the relationship between what he called the "spirit of science" and the Holocaust and in social history and the Weimar Republic. Peukert taught modern history at the University of Essen and served as director of the Research Institute for the History of the Nazi Period. Peukert was a member of the German Communist Party until 1978, when he joined the Social Democratic Party of Germany. A politically engaged historian, Peukert was known for his unconventional take on modern German history, and in an obituary, the British historian Richard Bessel wrote that it was a major loss that Peukert had died at the age of 39 as a result of AIDS.

Singapore is a major international transport hub in Asia, serving some of the busiest sea and air trade routes. Changi Airport is an aviation centre for Southeast Asia and a stopover on Qantas' Kangaroo Route between Sydney and London. There are two civilian airports in Singapore, Changi Airport and Seletar Airport. Changi Airport hosts a network of over 100 airlines connecting Singapore to some 300 cities in about 70 countries and territories worldwide. It has been rated one of the best international airports by international travel magazines, including being rated as the world's best airport for the first time in 2006 by Skytrax. It also had three of the ten busiest international air routes in the world in 2023: the busiest between Kuala Lumpur–Singapore, the seventh busiest between Jakarta–Singapore, and the ninth busiest between Bangkok–Singapore. Singapore Airlines, the flag carrier of Singapore, has been regarded as a 5-star airline by Skytrax and been in the world top 10 list of airlines for multiple consecutive years. It held the title of the World's Best Airline by Skytrax in 2023. It won this title 12 times. Its hub, Changi Airport had also been rated as the world's best airport from 2013 to 2020 before being superseded by Hamad International Airport in Doha. It reclaimed this title in 2023 before being superseded once more in 2024.

No visible clubbing – Fluctuation (increased ballotability) and softening of the nail bed only. No visible changes in nails. Mild clubbing – Loss of the normal <165° angle (Lovibond angle) between the nailbed and the fold (cuticula). Schamroth's window (see image) is obliterated. Clubbing is not obvious at a glance. Moderate clubbing – Increased convexity of the nail fold. Clubbing is apparent at a glance. Gross clubbing – Thickening of the whole distal (end part of the) finger (resembling a drumstick) Hypertrophic osteoarthropathy – Shiny aspect and striation of the nail and skin Schamroth's sign or Schamroth's window test (originally demonstrated by South African cardiologist Leo Schamroth on himself) is a popular test for clubbing. When the distal phalanges (bones nearest the fingertips) of corresponding fingers of opposite hands are directly opposed (place fingernails of the same finger on opposite hands against each other, nail to nail), a small diamond-shaped "window" is normally apparent between the nailbeds. If this window is obliterated, the test is positive, and clubbing is present.

== Pharmacokinetics == The pharmacokinetics of synephrine were studied by Hengstmann and Aulepp, who reported a peak plasma concentration at 1–2 hours, with an elimination half-life (T1/2) of ~ 2 hours.

Sources: en.wikipedia.org

Background from the literature

Ion mobility spectrometry (IMS) is a method of conducting analytical research that separates and identifies ionized molecules present in the gas phase based on the mobility of the molecules in a carrier buffer gas. Even though it is used extensively for military or security objectives, such as detecting drugs and explosives, the technology also has many applications in laboratory analysis, including studying small and big biomolecules. IMS instruments are extremely sensitive stand-alone devices, but are often coupled with mass spectrometry (MS), gas chromatography or high-performance liquid chromatography (HPLC) in order to achieve a multi-dimensional separation. They come in various sizes, ranging from a few millimetres to several metres depending on the specific application, and are capable of operating under a broad range of conditions. IMS instruments such as microscale high-field asymmetric-waveform ion mobility spectrometry can be palm-portable for use in a range of applications including volatile organic compound (VOC) monitoring, biological sample analysis, medical diagnosis and food quality monitoring. Systems operated at higher pressure (i.e. atmospheric conditions, 1 atm or 1013 hPa) are often accompanied by elevated temperature (above 100 °C), while lower pressure systems (1–20 hPa) do not require heating.

Canada's official national sports are ice hockey and lacrosse. Other major professional games include curling, basketball, baseball, soccer, and football. Great achievements in Canadian sports are recognized by numerous "Halls of Fame" and museums, such as Canada's Sports Hall of Fame. Canada shares several major professional sports leagues with the United States. Canadian teams in these leagues include seven franchises in the National Hockey League, three Major League Soccer teams, and one team in each of Major League Baseball and the National Basketball Association. Other popular professional competitions include the Canadian Football League, National Lacrosse League, the Canadian Premier League, and the curling tournaments hosted by Curling Canada. Canadians identified hockey as their preferred sport for viewing, followed by soccer and then basketball. In terms of participation, swimming was the most commonly reported sport by over one-third (35%) of Canadians in 2023. This was closely followed by cycling (33%) and running (27%). The popularity of specific sports varies; in general, the Canadian-born population was more likely to have participated in winter sports such as ice hockey (the most popular young adult team sport), skating, skiing and snowboarding, compared with immigrants, who were more likely to have played soccer (the most popular youth team sport), tennis or basketball. Sports such as golf, volleyball, badminton, bowling, and martial arts are also widely enjoyed at the youth and amateur levels.

== Efforts against proliferation == Antiproliferation or anti-proliferation: inhibiting cell multiplication; also efforts to slow, stop, or prevent the spread of weapons (nuclear, chemical, biological weapons, missiles) and technology, small arms, illicit drugs Counterproliferation or counter-proliferation: efforts to slow, stop, or prevent the spread of weapons (nuclear, chemical, biological weapons, missiles) and technology, small arms, illicit drugs

ferredoxin–nicotinamide adenine dinucleotide reductase ferredoxin reductase NAD+-ferredoxin reductase ferredoxin–NAD+ reductase ferredoxin–linked NAD+ reductase ferredoxin–NAD reductase When NAD molecule is in its reduced form, the enzyme is referred to as:

Urea is the parent for a class of chemical compounds that share the same functional group. Namely, such compounds have a carbonyl group attached to two organic amine residues: R1R2N−C(=O)−NR3R4, where R1, R2, R3 and R4 groups are hydrogen (–H), organyl or other groups. Examples include carbamide peroxide, allantoin, and hydantoin. Ureas are closely related to biurets and related in structure to amides, carbamates, carbodiimides, and thiocarbamides.

Sources: en.wikipedia.org

Frequently asked questions

Is AOD-9604 approved for weight loss?

No. Major drug regulators have not approved AOD-9604 for weight loss or any other therapeutic indication. It remains an investigational compound studied in research settings.

Why is AOD-9604 banned in sports?

The World Anti-Doping Agency classifies it as a prohibited peptide hormone. Athletes under anti-doping rules are not permitted to use it. Its presence can trigger a doping violation.

Does AOD-9604 raise growth hormone levels?

It is a fragment of growth hormone rather than a substance that signals the pituitary to release more hormone. Studies have not shown a consistent rise in IGF-1 or full growth hormone. Its metabolic effects, if any, appear separate from those of the complete hormone.

What is AOD-9604?

It is a synthetic peptide fragment derived from the C-terminal region of human growth hormone, commonly referred to as hGH fragment 176-191. It has been investigated for effects on fat metabolism, but it is not an approved medication in most jurisdictions.

Network